Question 1

Does Macquarie Group own CHRS stock?

Accepted Answer

No. Macquarie Group exited its CHRS (Coherus Oncology) position in Q4 2025. Its Q3 2025 13F listed 899,999 shares worth $1.5M.

Question 2

How many shares of CHRS does Macquarie Group own?

Accepted Answer

None since Q4 2025, when Macquarie Group exited the position. Its Q3 2025 13F listed 899,999 shares worth $1.5M.

Question 3

What is Macquarie Group's CHRS position worth?

Accepted Answer

Macquarie Group's CHRS position was worth $1.5M in its Q3 2025 13F, before the exit in Q4 2025.

Question 4

Is Macquarie Group buying or selling CHRS?

Accepted Answer

In Q4 2025, Macquarie Group exited its entire CHRS position.

Question 5

When did Macquarie Group first buy CHRS?

Accepted Answer

Macquarie Group already held CHRS in its Q4 2018 13F, the earliest on record, and listed it in 28 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price
2025-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$1.42
2025-Q3	Unchanged	899,999	0.0%	$1.5M	0.0%	$1.64
2025-Q2	Unchanged	899,999	0.0%	$658,000	0.0%	$0.73
2025-Q1	Unchanged	899,999	0.0%	$726,000	0.0%	$0.81
2024-Q4	Unchanged	899,999	0.0%	$1.2M	0.0%	$1.38
2024-Q3	Unchanged	899,999	0.0%	$936,000	0.0%	$1.04